WallStreetPR.com was co-founded by Brian Messineo and Mike Cornell in early 2012. Both are successful traders and investors who had historically made some of their best trades in NASDAQ high profiles before transitioning to small-cap stocks.
In today’s era of high volatility and global recessionary concerns, experience is a trader’s best friend. Through WallStreetPR, Brian and Mike have decided to share their knowledge and expertise with other investors. They have trained an eclectic team of financial analysts and writers from around the globe who provide insights into the financial sector.
Many articles on WallStreetPR cover topics that are neglected by traditional financial media companies. All articles are based on public information and cannot be guaranteed for accuracy. Individual writers or editors may commit typographical errors for which WallStreetPR.com cannot be held liable.
WallStreetPR was founded to provide informative and educational financial content. No information on the site shall be construed as an endorsement to buy or sell any securities. No writer is a certified financial professional in any jurisdiction and cannot provide personalized financial advice. For answers to your questions regarding the suitability of particular securities for your investment needs, please consult a registered firm in your area.
c/o Innovative Media
4051 Veterans Boulevard
Metairie, LA 70002
For biographical information about the staff of WallStreetPR, please click here.
Journal Transcripts - Winning in 2017!http://journaltranscript.com
Here’s how to leverage this breakthrough technology…
Cannabis Stocks Poise For Profithttp://mmjreporter.com
These 5 stocks set to explode as 2017 legislation
Enter The $100 Billion Gaming Markethttp://www.financialstrend.com
Gaming industry setup for explosive growth
2017 Most Disruptive Biotech CMXChttp://journaltranscript.com
Possibly The Biggest Diabetes Breakthrough Since Insulin
This is Default Discalimer. Please update this from the Intrinio Plugin setting page